Go to the list of all blogs
Scott Bell's Avatar
published in Blogs
Oct 22, 2026
TickeronGET DAILY SIGNALS
DOW vs LYB: Divergent Paths Amid Petrochemical Supply Shifts

DOW vs LYB: Divergent Paths Amid Petrochemical Supply Shifts

Key Takeaways

  • Both DOW and LYB have benefited from higher petrochemical prices following Middle East supply disruptions, but they are executing very different strategies.
  • DOW delivered a strong third quarter, beating earnings estimates on higher polyethylene prices and aggressive cost-cutting, and guided above expectations for the fourth quarter.
  • LYB posted a large second-quarter earnings beat and continues reshaping its portfolio, though near-term pricing pressure has led analysts to trim expectations.
  • DOW is leaning into self-help initiatives and workforce reductions, while LYB is divesting assets and streamlining its cost base through a cash improvement program.
  • Both stocks have outperformed the broader market over the past year, making relative performance and market positioning the key differentiators.

Setting the Stage

Dow Inc. and LyondellBasell Industries are two of the largest chemical and materials companies in the world, and their shares often move in tandem with the same forces: petrochemical pricing, energy costs, and global demand for plastics. A stock comparison between DOW and LYB is especially relevant now, because both have been navigating a disrupted global supply environment while pursuing separate restructuring paths. Investors focused on cyclicals, dividends, and materials-sector rotation may find this comparison useful for understanding how these peers differ in growth drivers, balance-sheet positioning, and market sentiment despite operating in closely related businesses. I also checked this using Tickeron’s AI Screener to see how the stocks compare to others in the industry.

DOW's Recent Results and Self-Help Focus

DOW is a Midland, Michigan–based materials science company that produces packaging and specialty plastics, industrial intermediates, and performance materials and coatings. In its most recent quarter, the company reported net sales of roughly $11.3 billion, up 13% year over year, with adjusted earnings per share of $0.71, ahead of consensus estimates. Operating EBITDA rose to about $1.55 billion from $868 million a year earlier.

Recent performance has been driven by higher polyethylene prices across all regions, which management attributed in part to tighter global supply following Middle East disruptions. The company has also accelerated self-help measures, including a plan to cut roughly 13% of its workforce and the closure of higher-cost European upstream assets. DOW guided fourth-quarter adjusted core earnings above Wall Street estimates, supported by continued pricing strength and cost savings, and its shares have risen sharply on a year-to-date basis, outpacing the S&P 500. From what I see, the cost discipline here stands out as a steadying factor.

LYB's Portfolio Reshaping and Near-Term Pressures

LYB, LyondellBasell Industries N.V., is a global chemical company headquartered in Houston, Texas, with roots in the Netherlands. It manufactures plastics, chemicals, and advanced polymers, and has been exiting lower-margin businesses to sharpen its focus. In its most recent reported quarter, the company posted EPS of $4.30, well above the consensus estimate of about $3.44, with revenue of roughly $9.18 billion, up nearly 20% year over year. That strength reflected higher polyethylene margins and favorable cost positioning for its U.S. Gulf Coast assets.

LYB has completed the sale of four European assets and continues to execute a cash improvement plan targeting $500 million of incremental cash flow. However, analysts have flagged softer third-quarter pricing as increased exports from China pressured polyethylene markets, prompting some firms to trim price targets even while maintaining constructive longer-term views. LYB shares have also delivered strong relative performance over the past year, though near-term sentiment has been more mixed ahead of its next earnings release. I’m watching this closely as the pricing dynamics evolve.

Direct Comparison of Strategies and Momentum

Although DOW and LYB share exposure to petrochemical pricing, their business models differ meaningfully. DOW operates a more integrated, downstream-oriented portfolio spanning packaging, infrastructure, and consumer-facing materials, while LYB is anchored in olefins and polyolefins with a cost-advantaged U.S. Gulf Coast position. Growth drivers also diverge: DOW is emphasizing self-help cost programs and productivity gains, whereas LYB is reshaping its portfolio through divestitures and disciplined capital spending.

On momentum, both stocks have outperformed the broader market over the past year, but the pattern differs. DOW's recent quarter showed broad-based improvement with an upbeat forward guide, while LYB faces near-term pricing headwinds even as its asset base remains structurally advantaged. Risk factors include commodity-price cyclicality, energy costs, and geopolitical supply disruptions for both. Market sentiment appears comparatively firmer around DOW's execution narrative, while analyst views on LYB are split between bullish cost-positioning arguments and concerns about softening pricing.

AI Assessment and Outlook

Based on observable factors, Tickeron's AI would likely lean toward DOW in the current environment. The combination of a broad-based earnings beat, an above-consensus forward outlook, and consistent self-help execution suggests steadier trend consistency and more visible near-term catalysts. LYB's cost-advantaged asset base and portfolio transformation remain credible long-term strengths, but softer third-quarter pricing and mixed analyst revisions introduce more uncertainty into its short-term trajectory. This is a probabilistic assessment grounded in momentum, stability, and relative positioning rather than a definitive forecast, and the balance could shift quickly if petrochemical pricing dynamics change.

Exploring Systematic Approaches in Materials

In my own research process, I often review Tickeron's Trending AI Robots page for a curated look at automated strategies active in sectors like chemicals. It highlights bots with strong recent momentum across different timeframes and styles, complete with performance stats, which helps me cross-check ideas without sifting through every option manually. This keeps the focus on data-driven signals that align with current market conditions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: LYB, DOW

Contributor

Scott Bell's AvatarScott Bell|Expert

I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking


LYB sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for LYB moved below the 200-day moving average on October 28, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LYB as a result. In 59 of 100 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 59%.

The Moving Average Convergence Divergence Histogram (MACD) for LYB turned negative on November 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 28 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 56%.

LYB moved below its 50-day moving average on November 16, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for LYB crossed bearishly below the 50-day moving average on November 17, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 42%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LYB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for LYB's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +2.96% 3-day Advance, the price is estimated to grow further. Considering data from situations where LYB advanced for three days, in 187 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.

LYB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 137 of 203 cases where LYB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 67%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.838) is normal, around the industry mean (2.284). P/E Ratio (-54.214) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (1.526) is also within normal values, averaging (1.548). Dividend Yield (0.045) settles around the average of (0.039) among similar stocks. P/S Ratio (0.670) is also within normal values, averaging (48.960).

The Tickeron PE Growth Rating for this company is 47 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating steady price growth. LYB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LYB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

Notable companies

The most notable companies in this group are DuPont de Nemours (NYSE:DD), Chemours Company (The) (NYSE:CC).

Industry description

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

Market Cap

The average market capitalization across the Chemicals: Specialty Industry is 11.6B. The market cap for tickers in the group ranges from 50 to 237.52B. LIN holds the highest valuation in this group at 237.52B. The lowest valued company is JSCPY at 50.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Specialty Industry was -9%. For the same Industry, the average monthly price growth was -14%, and the average quarterly price growth was -20%. MNTK experienced the highest price growth at 19%, while ASPI experienced the biggest fall at -37%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Specialty Industry was 63%. For the same stocks of the Industry, the average monthly volume growth was 38% and the average quarterly volume growth was 19%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 49
Price Growth Rating: 60
SMR Rating: 78
Profit Risk Rating: 85
Seasonality Score: -5 (-100 ... +100)
Trend Prediction Engine 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of petrochemicals

Industry ChemicalsSpecialty

Industry
Chemicals Specialty
Address
One Vine Street
Phone
+44 2072202600
Employees
18970
Web
https://www.lyondellbasell.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.